Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03482973 · ClinicalTrials.gov registry record · Phase 3
Pecto-Intercostal Fascial Block for Postoperative Analgesia After Cardiac Surgery
A Phase 3 study, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 80
- Enrollment target
NCT03482973 is a Phase 3 study that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 80 participants.
The verdict
NCT03482973, a Phase 3 study, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 80 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether administration of a pecto-intercostal fascial plane block (PIFB) with bupivacaine is a more effective therapy for postoperative analgesia after cardiac surgery as compared to patients who receive a sham block of normal saline.
Interventions
- OTHER Placebo
- DRUG Bupivacaine Group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2018-06-21 |
| Est. Completion | 2019-11-27 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03482973
The ClinicalTrials.gov registry entry for NCT03482973 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03482973 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03482973 about?
NCT03482973 is a clinical study titled "Pecto-Intercostal Fascial Block for Postoperative Analgesia After Cardiac Surgery". The purpose of this study is to determine whether administration of a pecto-intercostal fascial plane block (PIFB) with bupivacaine is a more effective therapy for postoperative analgesia after cardiac surgery as compared to patients who receive a sham block of normal saline.
What is the current status of trial NCT03482973?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 80 participants. The study started on 2018-06-21. Estimated completion is 2019-11-27.
What interventions are being tested in trial NCT03482973?
The interventions under investigation include: Placebo (OTHER), Bupivacaine Group (DRUG).
Who is sponsoring clinical trial NCT03482973?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.